Orion Immunogenics Private Limited - Company Profile

It is a healthcare private limited company based in Kolkata, West Bengal, India, established in 2000.
2000 Kolkata, West Bengal, India Struck Off
Last Updated:
Access Report
About Orion Immunogenics Private Limited

Orion Immunogenics Private Limited, a struck off private limited company, was established on 27 April 2000 in Kolkata, West Bengal, India. Engaging in nurses within the healthcare sector, it holds CIN: U85194WB2000PTC091749. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.49 M.

Its leadership includes Arijit Das (Director), Deep Narayan Dutta (Director), Jayati Das (Director). Its latest AGM occurred on 30 September 2010, with the balance sheet filed on 31 March 2010. It is based at 155A A J C Bose Road, Kolkata, West Bengal, 700014.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85194WB2000PTC091749

  • Registration Number

    091749

  • Incorporation Date

    27 April 2000

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.49 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.49 M
  • Company Age 25 Year, 10 Months
  • Last Filing with ROC 31 Mar 2010
Company report

Orion Immunogenics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Orion Immunogenics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Orion Immunogenics Private Limited?
Current Directors
Name Designation Appointment Date Status
Arijit Das Director 27 Apr 2000 Current
Deep Narayan Dutta Director 27 Apr 2000 Current
Jayati Das Director 01 Apr 2002 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orion Immunogenics.

Enhance accessibility to Orion Immunogenics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Orion Immunogenics revenue growth over time
Orion Immunogenics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orion Immunogenics?

Unlock access to Orion Immunogenics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Orion Immunogenics?

Unlock and access historical data on people associated with Orion Immunogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orion Immunogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orion Immunogenics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orion Immunogenics
Recent Activity within the Organization
  • Annual General Meeting

    The activity Orion Immunogenics Private Limited last Annual general meeting of members was held on 30 Sep 2010 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Orion Immunogenics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2010 with Roc Kolkata. was completed.

  • Director Appointment

    The activity Jayati Das was appointed as a Director was appointed as a Director on 01 Apr 2002 & has been associated with this company since 23 years 11 months . was completed.

  • Director Appointment

    The activity Arijit Das was appointed as a Director was appointed as a Director on 27 Apr 2000 & has been associated with this company since 25 years 10 months . was completed.

  • Director Appointment

    Deep Narayan Dutta was appointed as a Director was appointed as a Director on 27 Apr 2000 & has been associated with this company since 25 years 10 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Orion Immunogenics Private Limited was registered on 27 Apr 2000 with Roc Kolkata & aged 25 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Orion Immunogenics Private Limited?

The CIN of Orion Immunogenics Private Limited is U85194WB2000PTC091749.

Where is Orion Immunogenics Private Limited headquartered?

Orion Immunogenics Private Limited is headquartered at 155A A J C Bose Road, Kolkata, West Bengal, 700014.

When was Orion Immunogenics Private Limited incorporated?

Orion Immunogenics Private Limited was incorporated on 27 April 2000.

Who are the current directors of Orion Immunogenics Private Limited?

The current directors of Orion Immunogenics Private Limited are

What is the primary industry of Orion Immunogenics Private Limited?

The primary industry of Orion Immunogenics Private Limited is Healthcare.

Is Orion Immunogenics Private Limited a listed company?

Orion Immunogenics Private Limited is unlisted.

What is the capital structure of Orion Immunogenics Private Limited?

The authorized capital of Orion Immunogenics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.49 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available